Dissecting cancer through mathematics: from the cell to the animal model

HM Byrne - Nature Reviews Cancer, 2010 - nature.com
This Timeline article charts progress in mathematical modelling of cancer over the past 50
years, highlighting the different theoretical approaches that have been used to dissect the …

Hybrid models of tumor growth

KA Rejniak, ARA Anderson - Wiley Interdisciplinary Reviews …, 2011 - Wiley Online Library
Cancer is a complex, multiscale process in which genetic mutations occurring at a
subcellular level manifest themselves as functional changes at the cellular and tissue scale …

[HTML][HTML] Circulating angiogenic factors and the risk of preeclampsia

RJ Levine, SE Maynard, C Qian, KH Lim… - New England journal …, 2004 - Mass Medical Soc
Background The cause of preeclampsia remains unclear. Limited data suggest that excess
circulating soluble fms-like tyrosine kinase 1 (sFlt-1), which binds placental growth factor …

Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia

R Thadhani, H Hagmann… - Journal of the …, 2016 - journals.lww.com
Preeclampsia is a devastating complication of pregnancy. Soluble Fms-like tyrosine kinase-
1 (sFlt-1) is an antiangiogenic protein believed to mediate the signs and symptoms of …

Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia

R Thadhani, T Kisner, H Hagmann, V Bossung… - Circulation, 2011 - Am Heart Assoc
Background—Targeted therapies to stabilize the clinical manifestations and prolong
pregnancy in preeclampsia do not exist. Soluble fms-like tyrosine kinase 1 (sFlt-1), an …

Angiogenic factors in preeclampsia: from diagnosis to therapy

SA Karumanchi - Hypertension, 2016 - Am Heart Assoc
Karumanchi Angiogenic Factors and Preeclampsia 1073 to as fenestrations. Although it was
previously known that VEGF induces endothelial fenestrae in culture, 38 experimental data …

Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues

LLY Chiu, M Radisic - Biomaterials, 2010 - Elsevier
The aim of this study was to engineer a biomaterial capable of supporting vascularization in
vitro and in vivo. We covalently immobilized vascular endothelial growth factor (VEGF) and …

A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use

FTH Wu, MO Stefanini, FM Gabhann… - Journal of cellular …, 2010 - Wiley Online Library
Introduction‐Angiogenesis in physiology and pathology‐Angiogenesis in current medicine‐
VEGF ligand and receptor system: where does sVEGFR1 fit?‐Ligands: the human VEGF …

Systems biology of angiogenesis signaling: Computational models and omics

Y Zhang, H Wang, RHM Oliveira… - WIREs mechanisms …, 2022 - Wiley Online Library
Angiogenesis is a highly regulated multiscale process that involves a plethora of cells, their
cellular signal transduction, activation, proliferation, differentiation, as well as their …

[PDF][PDF] Tenascin-C downregulates wnt inhibitor dickkopf-1, promoting tumorigenesis in a neuroendocrine tumor model

F Saupe, A Schwenzer, Y Jia, I Gasser, C Spenlé… - Cell reports, 2013 - cell.com
The extracellular matrix molecule tenascin-C (TNC) is a major component of the cancer-
specific matrix, and high TNC expression is linked to poor prognosis in several cancers. To …